Trial Profile
Evaluation of a Structured Algorithm for Intrathecal Bolus Doses of Ziconotide (Prialt)- The Swedish Ziconotide Bolus Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2015
Price :
$35
*
At a glance
- Drugs Ziconotide (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms ZicBol
- 13 Nov 2012 Planned End Date changed from 1 Sep 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 19 Jun 2011 New trial record